SLU-PP-332 is a oral-format research product available from Royal Peptides. The listing provides its stated format, quantity, specifications and available batch documentation for qualified laboratory research.

What research category does SLU-PP-332 belong to?

SLU-PP-332 is categorized under mitochondrial and cellular-energy research. It may be examined in research involving mitochondrial function, cellular energy metabolism and oxidative signaling.

What research methods may involve SLU-PP-332?

Laboratory investigation of SLU-PP-332 may consider cellular-energy markers, oxidative signaling and controlled biochemical models. Appropriate controls, validated procedures and qualified interpretation are essential.

How does SLU-PP-332 compare with related research compounds?

SLU-PP-332 may differ from other mitochondrial and cellular-energy research compounds in structure, targets, signaling profile and experimental application. Comparisons should be based on published literature and controlled laboratory design.

Is third-party testing available for SLU-PP-332?

Available purity, mass, identity, endotoxin or other batch documentation for SLU-PP-332 may be reviewed on its product page or through the Royal Peptides COA library. Testing availability varies by product and batch.

What format is SLU-PP-332 supplied in?

SLU-PP-332 is supplied in the capsule or tablet format and quantity stated on the product page. Confirm the listed strength, count and packaging before ordering.

How should SLU-PP-332 be stored?

Keep SLU-PP-332 sealed, secured and protected from excessive heat, moisture and direct light. Follow the storage information displayed on the product page, packaging and applicable batch documentation.

Is SLU-PP-332 intended for human consumption?

No. SLU-PP-332 is offered strictly for laboratory and research use only. It is not intended for human consumption, medical treatment, diagnosis or veterinary use.

Batch documentation availableReview available analytical information for the selected research material.

Research Use Only Laboratory Research Materials

Royal Peptides products are offered exclusively for laboratory research, analytical, and scientific applications. Not for human or veterinary use.

01Research Product Information

Royal Peptides supplies compounds intended for controlled laboratory research and analytical applications.

For research and analytical use only
Not intended for human consumption or administration
Not intended for veterinary use
Not represented as a drug, medicine, or therapeutic product
Laboratory researchers are responsible for appropriate protocols and controls

Research Only Laboratory Material Analytical Use

02Lyophilized Product Format

Where applicable, Royal Peptides research materials are supplied in lyophilized form.

Lyophilization is a freeze-drying process used to remove moisture from material under controlled conditions.

Material appearance may differ between compounds and production lots
Lyophilized material may appear as a cake, film, or fragmented material
The quantity of visible material may appear small relative to vial size
Visual appearance alone does not establish identity or purity

03Storage & Laboratory Handling

Storage requirements may vary by compound, formulation, and production lot. Refer to the product label and available product-specific documentation.

Protect research materials from excessive heat
Limit unnecessary exposure to direct light and moisture
Keep containers securely closed when stored
Follow product-specific temperature requirements when provided
Use appropriate laboratory contamination-control procedures

04Packaging & Quality Documentation

Packaging components may vary slightly between production lots. This can include vial closures, cap styles, label positioning, and external packaging.

Check the product label and lot identifier before laboratory use
Inspect the vial and closure for visible shipping damage
Packaging design may differ between batches
Lot-specific analytical documentation may be available in our COA library

View COA Library

ROYAL RESEARCH CATALOG

SLU-PP-332

Research Material Batch Documentation Secure Checkout

Choose an option

10mg/50 caps
250mcg/100caps
500mcg/50caps
2mg/50caps
5mg/50caps

Clear selection

PLEASE REVIEW BEFORE ORDERING Important Product Notice

10-VIAL KITS — VIALS ARE NOT INDIVIDUALLY LABELED
10-vial research kits are supplied without individual vial labels. Product and batch identification are provided with the kit packaging.

RECONSTITUTION MATERIALS
For reconstitution-related research, use Royal Peptides® Reconstitution Solution ↗ or a genuine manufacturer-sealed Hospira® / Pfizer® product where applicable.

SUPPORT NOTICE
Support may be limited when unverified third-party materials are used.

01Research focusedLaboratory research materials

02DocumentedAvailable batch information

03TrackedOrder fulfillment updates

Secure payment VISA link $ ₿

RESEARCH NOTICE

For laboratory and research purposes only.Not intended for human consumption, diagnostic use, therapeutic use, or administration to humans or animals.

View Documentation →

Research Compound • 2026 Reference

SLU-PP-332 Research Compound

SLU-PP-332 is an experimental synthetic small-molecule pan-estrogen-related receptor agonist studied for activity across ERRα, ERRβ and ERRγ and for its role in preclinical research involving mitochondrial biology, oxidative metabolism, skeletal-muscle signaling and exercise-associated pathways.

Pan-ERR Agonist ERRα / ERRβ / ERRγ Small Molecule Mitochondrial Research Preclinical Research Research Use Only

Compound Class Synthetic Small Molecule

Research Targets ERRα / ERRβ / ERRγ

Pharmacology Pan-ERR Agonist

Research Status Preclinical

What Is SLU-PP-332?

SLU-PP-332 is a synthetic research compound developed as a pharmacological agonist of the estrogen-related receptor family of nuclear receptors.

Published experimental work characterizes SLU-PP-332 as active across ERRα, ERRβ and ERRγ, with greater potency toward ERRα reported in its original characterization.

Despite sometimes being grouped with peptide research products, SLU-PP-332 is not a peptide. It is a synthetic small molecule used experimentally to investigate pharmacological activation of estrogen-related receptor signaling.

How Does SLU-PP-332 Work in Research Models?

Estrogen-related receptors are transcriptional regulators associated with cellular energy metabolism. Experimental activation of these receptors provides researchers with a method for investigating ERR-dependent metabolic and mitochondrial pathways.

SLU-PP-332

ERRα / ERRβ / ERRγ

Transcriptional Signaling

Metabolic & Mitochondrial Research

ERR signaling has been associated with biological processes including oxidative phosphorylation, fatty-acid metabolism, mitochondrial function and energy utilization in metabolically active tissues.

SLU-PP-332 Research Areas

Published preclinical research has made SLU-PP-332 a useful experimental tool across several areas of metabolic and mitochondrial biology.

ERR Signaling

Investigation of pharmacological activation across the ERRα, ERRβ and ERRγ nuclear-receptor family.

Mitochondrial Biology

Research involving mitochondrial function, cellular respiration and pathways associated with oxidative energy metabolism.

Skeletal-Muscle Research

Experimental investigation of oxidative skeletal-muscle characteristics and exercise-associated transcriptional responses.

Energy Metabolism

Research involving fatty-acid oxidation, cellular energy utilization and ERR-regulated metabolic pathways.

SLU-PP-332 and PGC-1α

SLU-PP-332 is sometimes described online as a “PGC-1α activator.” That description can obscure its experimentally characterized primary pharmacology.

SLU-PP-332 is more precisely described as a synthetic pan-ERR agonist. PGC-1 family coactivators participate in broader transcriptional networks relevant to ERR signaling and mitochondrial energy metabolism.

Research classification: ERRα, ERRβ and ERRγ are the pharmacological receptor targets used to characterize SLU-PP-332. PGC-1α is relevant to the surrounding transcriptional biology rather than being presented as the compound's direct primary target.

SLU-PP-332 and Mitochondrial Research

The connection between estrogen-related receptors and cellular energy regulation is one reason SLU-PP-332 has attracted substantial research interest.

ERR-regulated transcription participates in pathways associated with mitochondrial function, oxidative phosphorylation, fatty-acid oxidation and cellular energy metabolism.

Synthetic ERR agonists therefore provide experimental tools for studying how pharmacological activation of these transcriptional networks affects metabolic and mitochondrial biology in preclinical models.

Why Is SLU-PP-332 Studied as an Exercise Mimetic?

SLU-PP-332 has received considerable research attention because preclinical studies have examined whether pharmacological ERR activation can reproduce selected molecular and metabolic responses associated with aerobic exercise.

This has led to SLU-PP-332 being discussed within the experimental “exercise mimetic” field.

Important distinction: “Exercise mimetic” is a research concept. It does not establish that SLU-PP-332 reproduces the broad cardiovascular, neurological, musculoskeletal and metabolic effects of physical exercise in humans.

Is SLU-PP-332 Orally Bioavailable?

Later published research identified lack of oral bioavailability as an important pharmacokinetic limitation of SLU-PP-332.

That limitation contributed to medicinal-chemistry research into chemically distinct pan-ERR agonists with different pharmacokinetic properties, including SLU-PP-915.

SLU-PP-915 subsequently demonstrated biological activity following oral administration in mouse research, creating an important experimental distinction between the two compounds.

Research Deep Dive

SLU-PP-332 vs SLU-PP-915

Compare ERR pharmacology, chemistry, oral activity, mitochondrial research and published preclinical evidence.

COMPARE COMPOUNDS →

SLU-PP-332 Metabolism Research

Analytical research published in 2026 further characterized the in-vitro metabolism of SLU-PP-332 using liver-derived experimental systems and high-resolution mass-spectrometry techniques.

The investigators reported nine SLU-PP-332 metabolites in the experimental systems studied, including six Phase-I metabolites and three Phase-II conjugates.

These findings contribute to analytical characterization and metabolite identification. In-vitro metabolism studies should not be interpreted as establishing human pharmacokinetics or clinical safety.

SLU-PP-332 Research FAQ

What is SLU-PP-332?

SLU-PP-332 is an experimental synthetic small molecule studied as an agonist of ERRα, ERRβ and ERRγ.

Is SLU-PP-332 a peptide?

No. SLU-PP-332 is a synthetic small molecule rather than a peptide chain.

What receptors does SLU-PP-332 target?

Published experimental research characterizes SLU-PP-332 as a pan-estrogen-related receptor agonist with activity across ERRα, ERRβ and ERRγ.

Is SLU-PP-332 a PGC-1α activator?

Its more precise pharmacological classification is a pan-ERR agonist. PGC-1 family coactivators are relevant to the broader transcriptional networks surrounding ERR signaling.

Why is SLU-PP-332 called an exercise mimetic?

Preclinical research has examined whether pharmacological ERR activation can reproduce selected molecular responses associated with aerobic exercise. The term describes a research concept and does not establish substitution for exercise in humans.

Is SLU-PP-332 orally bioavailable?

Published research has identified lack of oral bioavailability as a limitation of SLU-PP-332.

Has SLU-PP-332 demonstrated human clinical efficacy?

The research discussed here is preclinical. Laboratory and animal findings do not establish human clinical efficacy, dosing or safety.

Published SLU-PP-332 Research

Billon C, et al. (2023). Synthetic ERRα/β/γ Agonist Induces an ERRα-Dependent Acute Aerobic Exercise Response and Enhances Exercise Capacity. ACS Chemical Biology. PubMed →
Hampton CS, et al. (2023). Medicinal-chemistry research involving potent pan-ERR agonists and the subsequent development of SLU-PP-915. PubMed Central →
Billon C, et al. (2026). An orally active estrogen receptor-related receptor agonist, SLU-PP-915, enhances aerobic exercise capacity. PubMed →
Möller GM, et al. (2026). In Vitro Metabolism and Analytical Characterization of SLU-PP-332 and SLU-PP-915: Novel Pan-ERR Agonists With Doping Potential. Rapid Communications in Mass Spectrometry. PubMed →

Research Use Only: SLU-PP-332 is an experimental research compound. This material and the information presented here are intended for laboratory research and scientific-reference purposes only. Published laboratory and animal findings do not establish human dosing, efficacy or safety. Not for human consumption.

SLU-PP-332

SLU-PP-332 Research Compound

What Is SLU-PP-332?

How Does SLU-PP-332 Work in Research Models?